Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.675
+0.125 (8.06%)
At close: Feb 2, 2026, 4:00 PM EST
1.670
-0.005 (-0.30%)
After-hours: Feb 2, 2026, 4:00 PM EST
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $10.31 million as of February 2, 2026. Its market cap has decreased by -72.25% in one year.
Market Cap
10.31M
Enterprise Value
104.87K
1-Year Change
-72.25%
Ranking
Category
Stock Price
$1.68
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $10.31M, a decrease of -98.37%. That is a compound annual growth rate of -56.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 9.54M | -6.06% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | 631.18M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NuCana | 10.45M |
| BioRestorative Therapies | 10.12M |
| Edesa Biotech | 9.75M |
| Revelation Biosciences | 9.64M |
| Ernexa Therapeutics | 9.58M |
| Quince Therapeutics | 9.47M |
| Pulmatrix | 9.39M |
| CytoMed Therapeutics | 9.31M |